A molecular expression signature distinguishing follicular lesions in thyroid carcinoma using preamplification RT-PCR in archival samples

Liu, 2006, Follicular variant of papillary thyroid carcinoma: a clinicopathologic study of a problematic entity, Cancer, 107, 1255, 10.1002/cncr.22138 Lote, 1980, Familial occurrence of papillary thyroid carcinoma, Cancer, 46, 1291, 10.1002/1097-0142(19800901)46:5<1291::AID-CNCR2820460534>3.0.CO;2-Q DeLellis, 2004, WHO classification of thyroid and parathyroid tumours WHO classification of tumours, PatholGenet Tumours Endocrine Organs, 8, 49 Schmid, 2006, How to define follicular thyroid carcinoma?, Virchows Arch, 448, 385, 10.1007/s00428-006-0162-0 Rosai, 1992, Follicular carcinomas. Papillary carcinomas, 49 Baloch, 2005, Pathology, 422 Barden, 2003, Classification of follicular thyroid tumors by molecular signature: results of gene profiling, Clin Cancer Res, 9, 1792 Finn, 2007, Expression microarray analysis of papillary thyroid carcinoma and benign thyroid tissue: emphasis on the follicular variant and potential markers of malignancy, Virchows Arch, 450, 249, 10.1007/s00428-006-0348-5 Livak, 2001, Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method, Methods, 25, 402, 10.1006/meth.2001.1262 Kuramochi, 2006, Vascular endothelial growth factor messenger RNA expression level is preserved in liver metastases compared with corresponding primary colorectal cancer, Clin Cancer Res, 12, 29, 10.1158/1078-0432.CCR-05-1275 Azuma, 2006, Epidermal growth factor receptor and epidermal growth factor receptor variant III gene expression in metastatic colorectal cancer, Clin Colorectal Cancer, 6, 214, 10.3816/CCC.2006.n.038 Chen, 2006, Expression of syndecan-1 (CD138) in nasopharyngeal carcinoma is correlated with advanced stage and poor prognosis, Hum Pathol, 37, 1279, 10.1016/j.humpath.2006.04.024 Vernooy, 2007, Increased granzyme A expression in type II pneumocytes of patients with severe chronic obstructive pulmonary disease, Am J Respir Crit Care Med, 175, 464, 10.1164/rccm.200602-169OC Huang, 2001, Gene expression in papillary thyroid carcinoma reveals highly consistent profiles, Proc Natl Acad Sci USA, 98, 15044, 10.1073/pnas.251547398 Finley, 2004, Molecular profiling distinguishes papillary carcinoma from benign thyroid nodules, J Clin Endocrinol Metab, 89, 3214, 10.1210/jc.2003-031811 Lussier, 1997, A casein kinase I activity is constitutively associated with Nck, J Biol Chem, 272, 2688, 10.1074/jbc.272.5.2688 Kitabayashi, 1997, Cloning and chromosomal mapping of human casein kinase I gamma 2 (CSNK1G2), Genomics, 46, 133, 10.1006/geno.1997.4991 Miyagi, 2004, Chronic expression of RET/PTC 3 enhances basal and insulin-stimulated PI3 kinase/AKT signaling and increases IRS-2 expression in FRTL-5 thyroid cells, Mol Carcinog, 41, 98, 10.1002/mc.20042 Frittitta, 1999, Functional insulin receptors are overexpressed in thyroid tumors: is this an early event in thyroid tumorigenesis?, Cancer, 85, 492, 10.1002/(SICI)1097-0142(19990115)85:2<492::AID-CNCR30>3.0.CO;2-I Gross, 1998, Casein kinase I: spatial organization and positioning of a multifunctional protein kinase family, Cell Signal, 10, 699, 10.1016/S0898-6568(98)00042-4 Bioukar, 1999, Serine phosphorylation of the ligand-activated beta-platelet-derived growth factor receptor by casein kinase I-gamma2 inhibits the receptor's autophosphorylating activity, J Biol Chem, 274, 21457, 10.1074/jbc.274.30.21457 Marin, 2003, A noncanonical sequence phosphorylated by casein kinase 1 in beta-catenin may play a role in casein kinase 1 targeting of important signaling proteins, Proc Natl Acad Sci USA, 100, 10193, 10.1073/pnas.1733909100 Garcia-Rostan, 2001, Beta-catenin dysregulation in thyroid neoplasms: down-regulation, aberrant nuclear expression, and CTNNB1 exon 3 mutations are markers for aggressive tumor phenotypes and poor prognosis, Am J Pathol, 158, 987, 10.1016/S0002-9440(10)64045-X Garcia-Rostan, 1999, Frequent mutation and nuclear localization of beta-catenin in anaplastic thyroid carcinoma, Cancer Res, 59, 1811 Evans, 2005, Characterization of Rab23, a negative regulator of sonic hedgehog signaling, Methods Enzymol, 403, 759, 10.1016/S0076-6879(05)03066-1 Eggenschwiler, 2001, Rab23 is an essential negative regulator of the mouse Sonic hedgehog signalling pathway, Nature, 412, 194, 10.1038/35084089 Wicking, 2001, The role of hedgehog signalling in tumorigenesis, Cancer Lett, 173, 1, 10.1016/S0304-3835(01)00676-0 Daniel, 2006, Developmental signalling pathways in lung cancer, Respirology, 11, 234, 10.1111/j.1440-1843.2006.00838.x Karhadkar, 2004, Hedgehog signalling in prostate regeneration, neoplasia and metastasis, Nature, 431, 707, 10.1038/nature02962 Akiyoshi, 2006, Gli1, downregulated in colorectal cancers, inhibits proliferation of colon cancer cells involving Wnt signalling activation, Gut, 55, 991, 10.1136/gut.2005.080333 Athar, 2006, Hedgehog signalling in skin development and cancer, Exp Dermatol, 15, 667, 10.1111/j.1600-0625.2006.00473.x Suarez, 1998, Genetic alterations in human epithelial thyroid tumours, Clin Endocrinol (Oxford), 48, 531, 10.1046/j.1365-2265.1998.00443.x Suarez, 1988, Detection of activated ras oncogenes in human thyroid carcinomas, Oncogene, 2, 403 Lemoine, 1988, Activated ras oncogenes in human thyroid cancers, Cancer Res, 48, 4459 Carta, 2006, Genotyping of an Italian papillary thyroid carcinoma cohort revealed high prevalence of BRAF mutations, absence of RAS mutations and allowed the detection of a new mutation of BRAF oncoprotein (BRAF(V599lns)), Clin Endocrinol (Oxford), 64, 105, 10.1111/j.1365-2265.2005.02401.x Hwang, 2004, Regulation of signal transducer and activator of transcription 1 (STAT1) and STAT1-dependent genes by RET/PTC (rearranged in transformation/papillary thyroid carcinoma) oncogenic tyrosine kinases, Mol Endocrinol, 18, 2672, 10.1210/me.2004-0168 Sheils, 2000, ret/PTC-1 activation in hashimoto thyroiditis, Int J Surg Pathol, 8, 185, 10.1177/106689690000800305 Hunt, 2002, Loss of heterozygosity mutations of tumor suppressor genes in cytologically atypical areas in chronic lymphocytic thyroiditis, Endocr Pathol, 13, 321, 10.1385/EP:13:4:321 Sangalli, 2006, Fine needle aspiration cytology of the thyroid: a comparison of 5469 cytological and final histological diagnoses, Cytopathology, 17, 245, 10.1111/j.1365-2303.2006.00335.x Cheung, 2001, Analysis of ret/PTC gene rearrangements refines the fine needle aspiration diagnosis of thyroid cancer, J Clin Endocrinol Metab, 86, 2187, 10.1210/jcem.86.5.7504 Salvatore, 2004, Analysis of BRAF point mutation and RET/PTC rearrangement refines the fine-needle aspiration diagnosis of papillary thyroid carcinoma, J Clin Endocrinol Metab, 89, 5175, 10.1210/jc.2003-032221 Sapio, 2007, Detection of RET/PTC, TRK and BRAF mutations in preoperative diagnosis of thyroid nodules with indeterminate cytological findings, Clin Endocrinol (Oxford), 66, 678, 10.1111/j.1365-2265.2007.02800.x